FEB 28, 2014
Advanced Genomics in Clinical and Translational Research - Rare Disease Day
106 33 14569

 

 

Winter 2014 Webinar Series - February 28th - Rare Disease Day Genetic information is rapidly transforming the future of healthcare by enabling accurate and affordable diagnosis and prognosis, targeted treatments, and monitoring solutions. Life Technologies is committed to providing reliable and easy-to-use solutions, services, and support to meet the demanding needs of your work.

From scalable translational research solutions to proven clinical laboratory services and diagnostics, Life Technologies is a partner you can trust to help you efficiently develop and apply differentiated clinical applications today, and for many years into the future.

This quarterly webinar series will focus on topics in translational research and clinical diagnostics including pharmacogenomics, infectious disease, advances in cancer, inherited diseases, biomarker discovery and validation, Companion Diagnostics, reimbursement, assay validation and QC.

This event will bring together translational researchers, clinicians, laboratory professionals and experts from Life Technologies from around the world to learn about advances in advanced genomics. This conference offers an amazing opportunity as it is free to participants, and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues, without leaving the comfort of their office or home.

Conference participants will be able to:

 

 

 

 

  • Attend interactive live streaming video sessions
  • Have their questions answered in real-time by industry experts
  • Browse a virtual Life Technologies booth
  • Earn free CE continuing education credits

 

 


Speakers:
  • Jelili Ojodu, MPH, Director, Newborn Screening and Genetics, Association of Public Health Laboratories Mei Baker, MD, Associate Professor in the Department of Pediatrics, and Co-Director in
  • Director of Population Genomics, Enterprise Genomics Solutions Boston Site Leader, Life Sciences Solutions, Thermo Fisher Scientific
  • Associate Director, Genomic Analysis, Center for Genetic Medicine , Department of Pediatric Laboratory Medicine, The Hospital for Sick Children

Show Resources
Speakers

  • Jelili Ojodu, MPH, Mei Baker, MD, Anne Comeau, PhD
    Jelili Ojodu, MPH, Director, Newborn Screening and Genetics, Association of Public Health Laboratories Mei Baker, MD, Associate Professor in the Department of Pediatrics, and Co-Director in
    Biography
      Jelili Ojodu, MPH, is the director for Newborn Screening and Genetics at the Association of Public Health Laboratories (APHL). He is also the project director for the Newborn Screening Technical assistance and Evaluation Programs (NewSTEPs). Mr. Ojodu is responsible for providing guidance and direction for the Newborn Screening and Genetics in Public Health Program. Mr. Ojodu works closely with state newborn screening programs in the United States to assure their capacities and capabilities, and he is responsible for setting the overall strategic direction for the newborn screening and genetics program at APHL. He has collaborated on numerous training workshops, technical conferences, symposiums for newborn screening stakeholders. Prior to joining APHL, he spent several years at Georgetown University Medical Center on a National Institutes of Health initiative to reduce infant mortality in the District of Columbia as a research associate. He received his Masters in Public Health from The George Washington University and a Bachelor of Science degree in Biological Sciences from the University of Maryland, College Park. Dr. Baker is an associate professor in the Department of Pediatrics, and Co-Director in the Newborn Screening Laboratory at University of Wisconsin School of Medicine and Public Health. Dr. Baker received her medical education in China, and practiced medicine there before receiving molecular genetics training in the United States. By the time she joined the Wisconsin Newborn Screening Laboratory as an Associated Scientist in 2003, Dr. Baker had been working in the molecular genetics field for over 10 years, both in academic and industrial settings. After completing a two-year Clinical Biochemical Genetics fellowship at the Waisman Center of the University of Wisconsin-Madison in 2007, Dr. Baker accepted the Science Advisor position at the Newborn screening Laboratory of the Wisconsin State Laboratory of Hygiene, a joint appointment with a Clinical Health Science faculty position at the Department of Pediatrics at the University of Wisconsin School of Medicine and Public Health. Dr. Baker obtained her American Board Medical Genetics Certification in Clinical Biochemical Genetics in 2009. In addition to routine newborn screening, Dr. Bakers research interests include applications of molecular technology in newborn screening, and public health genetics and genomics. Dr. Baker currently serves on the Laboratory Standards and Procedures Subcommittee for the Secretarys advisory Committee on Heritable Disorders in Newborns and Children. She is a member of the Newborn Screening Molecular Subcommittee created by Center for Disease Control and prevention.(CDC) and Association of Public Health Laboratories (APHL).   Dr. Comeau is Deputy Director of the New England Newborn Screening Program and Professor of Pediatrics at the University of Massachusetts Medical School. The principal focus of Dr. Comeaus work has been population-based newborn screening. Technical advances from Dr. Comeaus laboratory have yielded sophisticated molecular assays for high-throughput population-based applications. Technical training in her laboratory and her faculty participation in national training workshops at CDC have ensured distribution of high quality bench capacities to providers working in domestic and international centers. Dr. Comeau has been an avid advocate of interdisciplinary evidence-based development and evaluation of newborn screening protocols. She has worked extensively with the CF Foundation on its newborn screening initiatives, chairs the Massachusetts CF and SCID newborn screening working groups, has been working with HRSA/APHL to promote the national adoption of sound case definitions for use by screeners and clinicians and is an active member of the Condition Review Group for External Reviews submitted to the Secretarys Advisory Committee. Her publications include development and evaluations of molecular applications in newborn screening, implications of expanded newborn screening on the healthcare community and recommendations for successful implementation of newborn screening programs such as cystic fibrosis and now SCID.  
    • Corina Shtir, PhD
      Director of Population Genomics, Enterprise Genomics Solutions Boston Site Leader, Life Sciences Solutions, Thermo Fisher Scientific
      Biography
        Corina Shtir is Director of Population Genomics and the Boston site leader for the Enterprise Genomics Solution (EGS) Team at Life Sciences Solutions, Thermo Fisher Scientific. She leads the Research & Development, Data Analysis and Interpretation of the EGS scientific group. Her work is focused on directing the execution of population-scale genomic medicine projects, and on designing and performing large-scale studies to identify disease-causing genes and genetic risk factors. Prior to joining Life Technologies, Dr. Shtir was a research scientist at the Wellcome Trust Sanger Center in the UK, where she led the data analysis for largest genetic study of Diabetes ever done. Corina is also specialized in: statistical modeling, population genetic studies, and the effect genetic ancestry has on disease association. She obtained her PhD in Biostatistics and Statistical Genetics at USC, and has performed PhD level work in Mathematics, Statistics, Population Genetics, Computational Biology, and Epidemiology.  
      • Christian Marshall, PhD
        Associate Director, Genomic Analysis, Center for Genetic Medicine , Department of Pediatric Laboratory Medicine, The Hospital for Sick Children
      Sponsored By

      For information on becoming a sponsor or exhibitor, please click here.


      Continuing Education (CME/CE/CEU) Credits

      The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


      Help

      General LabRoots Questions

      For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
      Contact us

      Virtual Events and Webinars

      Supported Configurations

      • Operating System Internet Explorer Firefox Chrome Safari
        Vista IE8+ FF10+ Chrome15+
        Windows 7 IE8+ FF10+ Chrome15+
        Windows 8 IE10 FF10+ Chrome15+
        Mac OS X   FF10+ Chrome15+ Safari5.1+
      • Cookie settings: session cookies enabled
      • Browser configuration must have JavaScript enabled
      • Adobe Flash player 10.2 or later

      To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

      Internet Connection

      • A minimum of 100Kbps is recommended for audio-only events
      • A minimum of 300Kbps is recommended for speaker on-video events

      Computer Equipment

      • Screen Resolution: Minimum 1024x768
      • Video Card: 65,000 colors minimum
      • Sound card and speakers (or headphones) for hearing webcast in full format
      • Audio Card: 16-bit minimum
      • RAM: 512MB of free RAM

      Firewall Protocol

      • HTTP on port 80 or HTTPS on port 443
      • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
      • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

      Work-At-Home Attendees

      • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

      For A Seamless Experience

      When using a mobile device, FREE Mobile Apps are available:

      - For viewing Webinars:

      - For viewing Virtual Events

      Attendee Guide

      • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

      Virtual Event and Webinar Support:

      Continuing Education (CME/CE) Support

      Loading Comments...
      Show Resources